Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_assertion type Assertion NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_head.
- NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_assertion description "[In order to evaluate the possible participation of P-glycoprotein (Pgp)-mediated multidrug resistance (MDR) in medulloblastoma therapy and its correlation with prognosis, archival specimens were examined by immuno-histochemistry utilizing 3 monoclonal antibodies against Pgp and 6 cases by reverse-transcriptase polymerase chain reaction (RT-PCR) using MDR1-specific primers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_provenance.
- NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_assertion evidence source_evidence_literature NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_provenance.
- NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_assertion SIO_000772 8743996 NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_provenance.
- NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_assertion wasDerivedFrom befree-20140225 NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_provenance.
- NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_assertion wasGeneratedBy ECO_0000203 NP534066.RAEXATN1YKdTql4btdiJvw3cbrDsScU_LZF64AVBpSM3w130_provenance.